Byron Robinson insider trades
Open-market stock purchases and sales by Byron Robinson, Chief Strategy Officer at Janux Therapeutics, Inc, from SEC Form 4 filings since Mar 1, 2022.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- JANX Janux Therapeutics, Inc: other filings, last Jan 2, 2025